Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer

PURPOSE: Metastatic breast cancer patients are usually exposed to taxane and anthracycline as neoadjuvant, adjuvant and palliative chemotherapeutic agents. This study was designed to determine the efficacy and safety of the use of a gemcitabine and cisplatin (GP) combination treatment in patients wi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kim, Jung Hwan, Oh, Sung Yong, Kwon, Hyuk-Chan, Lee, Suee, Kim, Sung-Hyun, Kim, Dae-Cheol, Lee, Jin-Hwa, Lee, Hyung-Sik, Cho, Se-Heun, Kim, Hyo-Jin
Formato: Artigo
Lenguaje:Inglês
Publicado: Korean Cancer Association 2008
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697461/
https://ncbi.nlm.nih.gov/pubmed/19688114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2008.40.3.101
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares